A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment

British Journal of Cancer, Published online: 17 May 2019; doi:10.1038/s41416-019-0473-yA phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment

http://feeds.nature.com/~r/bjc/rss/current/~3/xTMJB-0EEM0/s41416-019-0473-y

Source: British Journal of Cancer - May 16, 2019 Category: Cancer & Oncology Authors: Bora Lim Rashmi K. Murthy Jangsoon Lee Summer A. Jackson Toshiaki Iwase Darren W. Davis Jie S. Willey Jimin Wu Yu Shen Debu Tripathy Ricardo Alvarez Nuhad K. Ibrahim Abenaa M. Brewster Carlos H. Barcenas Powel H. Brown Sharon H. Giordano Stacy L. Moulder Source Type: research